Histiocytic Disorders
📧 Sign up to get email alerts when something new happens for Histiocytic Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Single-agent Cobimetinib for Adults With Histiocytic Disorders [Phase 2]
Phase 2 trial evaluating cobimetinib as a single agent for adults with histiocytic disorders has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
A Phase 2 pediatric MATCH trial evaluating selumetinib sulfate in relapsed or refractory advanced solid tumors, non-Hodgkin lymphoma, and hi…